#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Rhabdomyosarcoma Cognitive disorder Corneal neovascularisation Burkitt's lymphoma refractory Nephrotic syndrome Head and neck cancer Leukodystrophy Narcolepsy Spina bifida Hodgkin's disease Alexander disease Cutaneous T-cell lymphoma refractory Muscular dystrophy Alveolar proteinosis Acquired C1 inhibitor deficiency More trials…

Learn about Rare Diseases

Stevens-Johnson syndrome – Basic Information Aicardi-Goutieres syndrome – Diagnostics Idiopathic pulmonary fibrosis – Diagnostics Hypereosinophilic syndrome – Treatment Von Willebrand’s disease – Treatment Lysosomal storage disorder – Basic Information Usher’s syndrome – Basic Information Behcet’s syndrome – Basic Information Kearns-Sayre syndrome – Treatment Niemann-Pick disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Resomelagon ACETYLCARNITINE HYDROCHLORIDE Clindamycin Hydrochloride Cenobamate Frexalimab Poa Pratensis Pollen Extract Lutikizumab Azd8205 Ethanol (96 Per Cent) AMODIAQUINE Beclometasone Dipropionate Ecoo75 Arbaclofen Alks 2680 Cortisone Remibrutinib Pozelimab Afamelanotide Promazine Hydrochloride Trandolapril More therapies…

Learn about Your Condition

Amyotrophic lateral sclerosis Tinnitus Keratosis follicular Anaemia Skin cancer Systemic lupus erythematosus Leukocyte adhesion deficiency Colon cancer Anaemia of chronic disease Mastocytosis Habitual abortion Diabetic autonomic neuropathy Rectal cancer Childhood asthma Hypereosinophilic syndrome More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Acute lymphocytic leukaemia recurrent

A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

Not yet recruiting

1 1 1
Investigated Diseases:
- Acute lymphocytic leukaemia recurrent
- Acute lymphocytic leukaemia
Investigated Drugs:
- Blinatumomab
Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

Not recruiting

2 1 1 1
Investigated Drugs:
- Tisagenlecleucel
+2
Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Not recruiting

1 1 1 1
Investigated Drugs:
- Inotuzumab Ozogamicin
+7

1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Acute lymphocytic leukaemia recurrent

A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies